World Rare Disease Day Angel Sponge Day Event...BENOX Launch Symposium Results
Feb 25, 2025
|
Korea takes place on the occasion of World Rare Disease Day in 2025Pharmaceutical Co., Ltd. and the Korea Association for Rare and Intractable Diseases (hereinafter referred to as the Association) held a 'Angel Spoon Day' event for patients with rare and intractable diseases and their families.
With 10 patients with biliary obstruction participating, the event, held at Lotte World in Songpa-gu, Seoul, gave the family a meaningful time to get out of their daily care for a while, gain new vitality and communicate with each other.
Marking its third anniversary this year, the 'Angel Sponge Day' aims to provide psychological stability and vitality for families with rare and incurable diseasesIt is a social contribution activity that Pharmaceutical has been sponsoring. The program, designed based on the reality of caregivers who have difficulty taking a break or personal time due to the burden of care, focuses on helping patients and their families participate in the program together to restore physical and emotional vitality and strengthen their will to overcome the disease.
This year's event invited patients and their families suffering from bile duct obstruction. A patient family from the Biliary Closure Friendship Association (hereinafter referred to as the Damwoo Association) who attended the event will take place in KoreaHe participated in the program by team matching with volunteers of pharmaceutical executives and employees.
Biliary obstruction is a rare disease that can progress to liver damage and cirrhosis as part or all of a newborn's extrahepatic biliary tract is blocked and bile cannot be discharged normally. If biliary obstruction is diagnosed due to poor prognosis, Casai surgery is needed to connect the liver and small intestine early, and ultimately liver transplantation is needed.
|
Dongguk Pharmaceutical held a 'Vienox Launch Symposium' at the Anywhere Hall on Chaebit Island, Seocho-gu, Seoul on the 22nd.
About 100 medical staff attended the event to officially announce Dongkuk Pharmaceutical's botulinum toxin preparation 'Vienoxju' and share the latest procedural trends using it, and it consists of training dkma (Dongguk Pharmaceutical Medical Aesthetic) items and procedures and suggesting practical and safe procedural guides that can be applied to hospitals and clinics.
At the symposium, three experts participated to share various procedures. ▲ Director Park Soo-yeon (Made Young Plastic Surgery) presented the theme of 'Body Contouring Procedure Using Botulinum Toxin and HA Pillar', while Director Hong Jong-wook (Waterdrop Plastic Surgery) introduced 'Effective Dermatoxin Treatment Using Botulinum Toxin and Skin Booster'. ▲Director Lee Eun-ji (DANA Clinic) shared the latest clinical application cases by presenting the trend-setting facial procedures using botulinum toxin and highly cohesive and elastic HA filler cablerin.
|
JW Pharmaceutical has introduced a health functional food '10 billion probiotic probiotic lactobacillus Max' containing probiotics that can help to proliferate lactobacilli and suppress harmful bacteria.
By applying U.S. patented coating technology that increases lactobacillus survival in the body, it is designed to ensure that lactobacillus can reach the intestines stably when taking products, and 10 billion lactobacilli are guaranteed in one product. In addition, zinc, which is essential for maintaining normal immune function, can be added to improve immunity, and the yogurt-flavored powder stick design is adopted so that children to adults can easily eat it without feeling rejected.
This article was translated by Naver AI translator.
